-
1
-
-
84886783174
-
Risk of surgery for infl ammatory bowel diseases has decreased over time: A systematic review and metaanalysis of population-based studies
-
Frolkis AD , Dykeman J , Negron ME et al. Risk of surgery for infl ammatory bowel diseases has decreased over time: A systematic review and metaanalysis of population-based studies . Gastroenterology 2013 ; 145 : 996-1006
-
(2013)
Gastroenterology
, vol.145
, pp. 996-1006
-
-
Frolkis, A.D.1
Dykeman, J.2
Negron, M.E.3
-
2
-
-
83755219473
-
Increasing incidence and prevalence of the infl ammatory bowel diseases with time, based on systematic review
-
quiz e30
-
Molodecky NA , Soon IS , Rabi DM et al. Increasing incidence and prevalence of the infl ammatory bowel diseases with time, based on systematic review . Gastroenterology 2012 ; 142 : 46-54 e42; quiz e30
-
(2012)
Gastroenterology
, vol.142
, pp. 46-54e42
-
-
Molodecky, N.A.1
Soon, I.S.2
Rabi, D.M.3
-
3
-
-
56749105799
-
The eff ect of smoking aft er surgery for crohn's disease: A meta-analysis of observational studies
-
Reese GE , Nanidis T , Borysiewicz C et al. The eff ect of smoking aft er surgery for Crohn's disease: A meta-analysis of observational studies . Intl J Colorectal Dis 2008 ; 23 : 1213-21
-
(2008)
Intl J Colorectal Dis
, vol.23
, pp. 1213-1221
-
-
Reese, G.E.1
Nanidis, T.2
Borysiewicz, C.3
-
4
-
-
9144228789
-
Risk of early surgery for crohn's disease: Implications for early treatment strategies
-
Sands BE , Arsenault JE , Rosen MJ et al. Risk of early surgery for Crohn's disease: Implications for early treatment strategies . Am J Gastroenterol 2003 ; 98 : 2712-8
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2712-2718
-
-
Sands, B.E.1
Arsenault, J.E.2
Rosen, M.J.3
-
5
-
-
0035087887
-
Smoking cessation and the course of crohn's disease: An intervention study
-
Cosnes J , Beaugerie L , Carbonnel F et al. Smoking cessation and the course of Crohn's disease: An intervention study . Gastroenterology 2001 ; 120 : 1093-9
-
(2001)
Gastroenterology
, vol.120
, pp. 1093-1099
-
-
Cosnes, J.1
Beaugerie, L.2
Carbonnel, F.3
-
6
-
-
0024803939
-
A meta-analysis of the role of smoking in infl ammatory bowel disease
-
Calkins BM . A meta-analysis of the role of smoking in infl ammatory bowel disease . Dig Dis Sci 1989 ; 34 : 1841-54
-
(1989)
Dig Dis Sci
, vol.34
, pp. 1841-1854
-
-
Calkins, B.M.1
-
8
-
-
77953307288
-
Environmental risk factors for infl ammatory bowel disease
-
Molodecky NA , Kaplan GG . Environmental risk factors for infl ammatory bowel disease . Gastroenterol Hepatol (NY) 2010 ; 6 : 339-46
-
(2010)
Gastroenterol Hepatol (NY
, vol.6
, pp. 339-346
-
-
Molodecky, N.A.1
Kaplan, G.G.2
-
9
-
-
84873717324
-
High smoking cessation rate in crohn's disease patients aft er physician advice-The tabacrohn study
-
Nunes T , Etchevers MJ , Merino O et al. High smoking cessation rate in Crohn's disease patients aft er physician advice-The TABACROHN Study. J Crohns Colitis 2012 ; 7 : 202-7
-
(2012)
J Crohns Colitis
, vol.7
, pp. 202-207
-
-
Nunes, T.1
Etchevers, M.J.2
Merino, O.3
-
10
-
-
84924458322
-
High smoking cessation rate in crohns disease patients attending a multicenter anti-Tobacco program: The tabacrohn study
-
San Diego CA USA
-
Nunes T , Etchevers MJ , Merino O et al. High smoking cessation rate in Crohns disease patients attending a multicenter anti-Tobacco program: The TABACROHN Study . Dig Dis Week 2012 : San Diego CA, USA , 2012
-
(2012)
Dig Dis Week
-
-
Nunes, T.1
Etchevers, M.J.2
Merino, O.3
-
11
-
-
84868514758
-
Infl ammatory bowel disease: A canadian burden of illness review
-
Rocchi A , Benchimol EI , Bernstein CN et al. Infl ammatory bowel disease: A Canadian burden of illness review . Can J Gastroenterol 2012 ; 26 : 811-7
-
(2012)
Can J Gastroenterol
, vol.26
, pp. 811-817
-
-
Rocchi, A.1
Benchimol, E.I.2
Bernstein, C.N.3
-
12
-
-
33750296341
-
-
Canadian Agency for Drugs and Technologies in Health 3rd Edition] Accessed 29 January 2014
-
Canadian Agency for Drugs and Technologies in Health . Guidelines for the economic evaluation of health technologies: Canada [3rd Edition]. 2006 http://www.cadth.ca/media/pdf/186-EconomicGuidelines-e.pdf. Accessed 29 January 2014
-
(2006)
Guidelines for the Economic Evaluation of Health Technologies: Canada
-
-
-
13
-
-
85016499545
-
Individual behavioural counselling for smoking cessation
-
Lancaster T , Stead LF . Individual behavioural counselling for smoking cessation . Cochrane Database Syst Rev 2005 ; 2 : CD001292
-
(2005)
Cochrane Database Syst Rev
, vol.2
, pp. CD001292
-
-
Lancaster, T.1
Stead, L.F.2
-
17
-
-
10744224387
-
Comparison of scheduled and episodic treatment strategies of infl iximab in crohn's disease
-
Rutgeerts P , Feagan BG , Lichtenstein GR et al. Comparison of scheduled and episodic treatment strategies of infl iximab in Crohn's disease . Gastroenterology 2004 ; 126 : 402-13
-
(2004)
Gastroenterology
, vol.126
, pp. 402-413
-
-
Rutgeerts, P.1
Feagan, B.G.2
Lichtenstein, G.R.3
-
18
-
-
33846242958
-
Adalimumab for maintenance of clinical response and remission in patients with crohn's disease: The charm trial
-
Colombel JF , Sandborn WJ , Rutgeerts P et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial . Gastroenterology 2007 ; 132 : 52-65
-
(2007)
Gastroenterology
, vol.132
, pp. 52-65
-
-
Colombel, J.F.1
Sandborn, W.J.2
Rutgeerts, P.3
-
19
-
-
62049083383
-
Loss of response and requirement of infl iximab dose intensifi cation in crohn's disease: A review
-
Gisbert JP , Panes J . Loss of response and requirement of infl iximab dose intensifi cation in Crohn's disease: A review . Am J Gastroenterol 2009 ; 104 : 760-7
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 760-767
-
-
Gisbert, J.P.1
Panes, J.2
-
20
-
-
79953786419
-
Loss of response and need for adalimumab dose intensifi cation in crohn's disease: A systematic review
-
Billioud V , Sandborn WJ , Peyrin-Biroulet L . Loss of response and need for adalimumab dose intensifi cation in Crohn's disease: A systematic review. Am J Gastroenterol 2011 ; 106 : 674-84
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 674-684
-
-
Billioud, V.1
Sandborn, W.J.2
Peyrin-Biroulet, L.3
-
21
-
-
84924453263
-
-
Statistics Canada Accessed 10 June 2012
-
Statistics Canada . Age-Standardized mortality rates by selected causes, by sex. 2009 http://www.statcan.gc.ca/tables-Tableaux/sum-som/l01/cst01/health30a-eng.htm . Accessed 10 June 2012
-
(2009)
Age-Standardized Mortality Rates by Selected Causes, by Sex
-
-
-
22
-
-
73949147970
-
Overall and cause-specifi c mortality in crohn's disease: A meta-analysis of population-based studies
-
Duricova D , Pedersen N , Elkjaer M et al. Overall and cause-specifi c mortality in Crohn's disease: A meta-analysis of population-based studies. Infl amm Bowel Dis 2010 ; 16 : 347-53
-
(2010)
Infl Amm Bowel Dis
, vol.16
, pp. 347-353
-
-
Duricova, D.1
Pedersen, N.2
Elkjaer, M.3
-
23
-
-
63349111119
-
Does smoking reduce infl iximab's eff ectiveness against Crohn's disease?
-
Narula N , Fedorak RN . Does smoking reduce infl iximab's eff ectiveness against Crohn's disease? Can J Gastroenterol 2009 ; 23 : 121-5
-
(2009)
Can J Gastroenterol
, vol.23
, pp. 121-125
-
-
Narula, N.1
Fedorak, R.N.2
-
24
-
-
71949105445
-
Systematic review: The short-Term and long-Term effi cacy of adalimumab following discontinuation of infl iximab
-
Ma C , Panaccione R , Heitman SJ et al. Systematic review: The short-Term and long-Term effi cacy of adalimumab following discontinuation of infl iximab . Aliment Pharmacol Ther 2009 ; 30 : 977-86
-
(2009)
Aliment Pharmacol Ther
, vol.30
, pp. 977-986
-
-
Ma, C.1
Panaccione, R.2
Heitman, S.J.3
-
25
-
-
79751472562
-
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: When to start, when to stop which drug to choose, and how to predict response?
-
quiz 213
-
D'Haens GR , Panaccione R , Higgins PD et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: When to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol 2011 ; 106 : 199-212 , quiz 213
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 199-212
-
-
D'Haens, G.R.1
Panaccione, R.2
Higgins, P.D.3
-
26
-
-
84924515896
-
-
Alberta Blue Cross Accessed 19 February 2014
-
Alberta Blue Cross. Alberta Blue Cross Interactive Drug Benefi t List. 2014 https://idbl.ab.bluecross.ca/idbl/load.do . Accessed 19 February 2014
-
(2014)
Alberta Blue Cross Interactive Drug Benefit List
-
-
-
27
-
-
84858752735
-
Cost per treated patient for etanercept, adalimumab, and infl iximab across adult indications: A claims analysis
-
Bonafede MM , Gandra SR , Watson C et al. Cost per treated patient for etanercept, adalimumab, and infl iximab across adult indications: A claims analysis . Adv Ther 2012 ; 29 : 234-48
-
(2012)
Adv Ther
, vol.29
, pp. 234-248
-
-
Bonafede, M.M.1
Gandra, S.R.2
Watson, C.3
-
28
-
-
84924452642
-
-
Bureau of Labor Statistics Accessed 24 February 2014
-
Bureau of Labor Statistics . Consumer Price Index (United States of America). 2014 http://www.bls.gov/cpi/ . Accessed 24 February 2014
-
(2014)
Consumer Price Index (United States of America
-
-
-
29
-
-
0003617159
-
-
Statistics Canada Accessed 19 February 2014
-
Statistics Canada . Consumer Price Index. 2014 http://www.statcan.gc.ca/tables-Tableaux/sum-som/l01/cst01/econ09a-eng.htm . Accessed 19 February 2014
-
(2014)
Consumer Price Index
-
-
-
30
-
-
0033967019
-
The cost of hospitalization in crohn's disease
-
Cohen RD , Larson LR , Roth JM et al. The cost of hospitalization in Crohn's disease . Am J Gastroenterol 2000 ; 95 : 524-30
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 524-530
-
-
Cohen, R.D.1
Larson, L.R.2
Roth, J.M.3
-
31
-
-
84863983658
-
Direct medical cost of managing ibd patients: A canadian population-based study
-
Bernstein CN , Longobardi T , Finlayson G et al. Direct medical cost of managing IBD patients: A Canadian population-based study . Infl amm Bowel Dise 2011 ; 18 : 1498-508
-
(2011)
Infl Amm Bowel Dise
, vol.18
, pp. 1498-1508
-
-
Bernstein, C.N.1
Longobardi, T.2
Finlayson, G.3
-
32
-
-
0001051932
-
An evaluation of utility measurement in crohn's disease
-
Gregor JC , McDonald JWD , Klar N et al. An evaluation of utility measurement in Crohn's disease . Infl amm Bowel Dis 1997 ; 3 : 265-76
-
(1997)
Infl Amm Bowel Dis
, vol.3
, pp. 265-276
-
-
Gregor, J.C.1
McDonald, J.W.D.2
Klar, N.3
-
33
-
-
84901508464
-
Environmental factors in a population-based inception cohort of infl ammatory bowel disease patients in europe-an ecco-epicom study
-
Burisch J , Pedersen N , Cukovic-Cavka S et al. Environmental factors in a population-based inception cohort of infl ammatory bowel disease patients in Europe-An ECCO-EpiCom study . J Crohns Colitis 2013 ; 8 : 607-16
-
(2013)
J Crohns Colitis
, vol.8
, pp. 607-616
-
-
Burisch, J.1
Pedersen, N.2
Cukovic-Cavka, S.3
-
34
-
-
33947546191
-
Update on the incidence and prevalence of crohn's disease and ulcerative colitis in olmsted county, minnesota 1940-2000
-
Loft us CG , Loft us EV Jr. , Harmsen WS et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000 . Infl amm Bowel Dis 2007 ; 13 : 254-61
-
(2007)
Infl Amm Bowel Dis
, vol.13
, pp. 254-261
-
-
Loftus, C.G.1
Loftus, E.V.2
Harmsen, W.S.3
-
35
-
-
0005536502
-
-
U.S. and World Population Clock Accessed 8 December 2013
-
United States Census Bureau. U.S. and World Population Clock . http://www.census.gov/popclock/ . Accessed 8 December 2013
-
United States Census Bureau
-
-
-
36
-
-
84902659142
-
Defining quality indicators for bestpractice management of infl ammatory bowel disease in canada
-
Nguyen GC , Devlin SM , Afi f W et al. Defi ning quality indicators for bestpractice management of infl ammatory bowel disease in Canada . Can J Gastroenterol Hepatol 2014 ; 28 : 275-85
-
(2014)
Can J Gastroenterol Hepatol
, vol.28
, pp. 275-285
-
-
Nguyen, G.C.1
Devlin, S.M.2
Afif, W.3
-
37
-
-
84864053696
-
Assessment of variables associated with smoking cessation in crohn's disease
-
Leung Y , Kaplan GG , Rioux KP et al. Assessment of variables associated with smoking cessation in Crohn's disease . Dig Dis Sci 2012 ; 57 : 1026-32
-
(2012)
Dig Dis Sci
, vol.57
, pp. 1026-1032
-
-
Leung, Y.1
Kaplan, G.G.2
Rioux, K.P.3
-
38
-
-
84884187859
-
Eff ects of varenicline on smoking cessation in adults with stably treated current or past major depression: A randomized trial
-
Anthenelli RM , Morris C , Ramey TS et al. Eff ects of varenicline on smoking cessation in adults with stably treated current or past major depression: A randomized trial . Ann Intern Med 2013 ; 159 : 390-400
-
(2013)
Ann Intern Med
, vol.159
, pp. 390-400
-
-
Anthenelli, R.M.1
Morris, C.2
Ramey, T.S.3
-
39
-
-
84891791619
-
Pharmacological interventions for smoking cessation: An overview and network meta-analysis
-
Cahill K , Stevens S , Perera R et al. Pharmacological interventions for smoking cessation: An overview and network meta-analysis . Cochrane Database Syst Rev 2013 ; 5 : CD009329
-
(2013)
Cochrane Database Syst Rev
, vol.5
, pp. CD009329
-
-
Cahill, K.1
Stevens, S.2
Perera, R.3
-
40
-
-
84889028067
-
Varenicline, smoking cessation, and neuropsychiatric adverse events
-
Gibbons RD , Mann JJ . Varenicline, smoking cessation, and neuropsychiatric adverse events . Am J Psychiatry 2013 ; 170 : 1460-7
-
(2013)
Am J Psychiatry
, vol.170
, pp. 1460-1467
-
-
Gibbons, R.D.1
Mann, J.J.2
-
41
-
-
84924445343
-
-
U.S. Food Drug Administration Accessed 24 May 2014
-
U.S. Food and Drug Administration . Postmarket Drug Safety Information for Patients and Providers (Varenicline). 2014 http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsand Providers/ucm124818.htm . Accessed 24 May 2014
-
(2014)
Postmarket Drug Safety Information for Patients and Providers (Varenicline
-
-
-
42
-
-
84924512057
-
-
Alberta Health Services Accessed 19 February 2014
-
Alberta Health Services . Alberta Health Services Job Board. 2014 http://www.albertahealthservices.ca/careers/ . Accessed 19 February 2014
-
(2014)
Alberta Health Services Job Board
-
-
-
43
-
-
84924483159
-
-
Addiction Centre Accessed 6 June 2012
-
Alberta Health Services . Addiction Centre. 2012 www.addictioncentre.ca. Accessed 6 June 2012
-
(2012)
Alberta Health Services
-
-
|